Efficacy of Donor and ‘Third Party’ (Tabelecleucel) EBV-Specific T Cells for Treatment of Central Nervous System (CNS) EBV-PTLD
Sign Up to like & getrecommendations! Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.158
Abstract: Background EBV+PTLD is a life-threatening complication after hematopoietic cell transplantation (HCT) and solid organ transplantation (SOT). Introduction of EBV-specific T-cells (EBV+CTLs) as second line treatment after rituximab has reduced overall EBV+PTLD related mortality. Due to… read more here.
Keywords: cns ebv; ebv; ebv ptld; ebv ctls ... See more keywords
EBV‐specific cytotoxic T lymphocytes for refractory EBV‐associated post‐transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review
Sign Up to like & getrecommendations! Published in 2021 at "Transplant International"
DOI: 10.1111/tri.14107
Abstract: The use of Epstein–Barr virus‐specific cytotoxic T lymphocytes (EBV‐CTLs) in adoptive immunotherapy in hematopoietic stem cell transplantation (HSCT) patients with post‐transplantation lymphoproliferative disorder (PTLD) has demonstrated safety and effectiveness. EBV‐CTLs might also be the effective… read more here.
Keywords: ptld; ebv ctls; specific cytotoxic; lymphoproliferative disorder ... See more keywords